About Fluidx Medical Technology
Fluidx Medical Technology is a private company based in Salt Lake City, Utah. It has reported $14,331,487 raised in four offerings on Form D since March 2023. Its chief executive is Karen Ginster.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 22, 2024 | Apr 3, 2024amended May 3, 2024 | $1,268,349of $1.2M target | 19 | $66,755 | Equity, Series A Preferred StockRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 15, 2021 | Mar 20, 2023 | $7,557,654fully sold | 26 | $290K | Equity, Series A Preferred StockRule 506(b) | Form D ↗ |
| Nov 10, 2020 | Mar 20, 2023 | $3,150,482fully sold | 13 | $242K | Equity, Series Seed 2 Preferred StockRule 506(b) | Form D ↗ |
| Nov 10, 2020 | Mar 20, 2023 | $2,355,002fully sold | 6 | $392K | Equity, Series Seed 1 Preferred StockRule 506(b) | Form D ↗ |
| Total, four offerings | $14,331,487 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Fluidx Medical Technology's Form D filed May 3, 2024.
MD
Michael Dake
Director
SF
Shawn Fojtik
Director
GF
Greg Fredde
Director
JM
James McGUCKIN
Director
KG
Karen Ginster
Chief Executive Officer and director
Earlier filings also listed Lawrence Kronick (director, last listed Mar 2023).